Interim estimates of the effectiveness of seasonal trivalent inactivated influenza vaccine in preventing influenza hospitalisations and primary care visits in Auckland, New Zealand, in 2014

N. Turner, N. Pierse, Q. S. Huang, S. Radke, A. Bissielo, M. G. Thompson, H. Kelly, on behalf of the SHIVERS investigation team

Research output: Contribution to journalArticleResearchpeer-review

18 Citations (Scopus)

Abstract

We present preliminary results of influenza vaccine effectiveness (VE) in New Zealand using a case test- negative design for 28 April to 31 August 2014. VE adjusted for age and time of admission among all ages against severe acute respiratory illness hospital presentation due to laboratory-confirmed influenza was 54% (95% CI: 19 to 74) and specifically against A(H1N1) pdm09 was 65% (95% CI:33 to 81). For influenza-con- firmed primary care visits, VE was 67% (95% CI: 48 to 79) overall and 73% (95% CI: 50 to 85) against A(H1N1) pdm09.

Original languageEnglish
Number of pages6
JournalEurosurveillance
Volume19
Issue number42
Publication statusPublished - 23 Oct 2014

Cite this

Turner, N., Pierse, N., Huang, Q. S., Radke, S., Bissielo, A., Thompson, M. G., ... on behalf of the SHIVERS investigation team (2014). Interim estimates of the effectiveness of seasonal trivalent inactivated influenza vaccine in preventing influenza hospitalisations and primary care visits in Auckland, New Zealand, in 2014. Eurosurveillance, 19(42).
Turner, N. ; Pierse, N. ; Huang, Q. S. ; Radke, S. ; Bissielo, A. ; Thompson, M. G. ; Kelly, H. ; on behalf of the SHIVERS investigation team. / Interim estimates of the effectiveness of seasonal trivalent inactivated influenza vaccine in preventing influenza hospitalisations and primary care visits in Auckland, New Zealand, in 2014. In: Eurosurveillance. 2014 ; Vol. 19, No. 42.
@article{109806574c1e46f4bc55118167452d53,
title = "Interim estimates of the effectiveness of seasonal trivalent inactivated influenza vaccine in preventing influenza hospitalisations and primary care visits in Auckland, New Zealand, in 2014",
abstract = "We present preliminary results of influenza vaccine effectiveness (VE) in New Zealand using a case test- negative design for 28 April to 31 August 2014. VE adjusted for age and time of admission among all ages against severe acute respiratory illness hospital presentation due to laboratory-confirmed influenza was 54{\%} (95{\%} CI: 19 to 74) and specifically against A(H1N1) pdm09 was 65{\%} (95{\%} CI:33 to 81). For influenza-con- firmed primary care visits, VE was 67{\%} (95{\%} CI: 48 to 79) overall and 73{\%} (95{\%} CI: 50 to 85) against A(H1N1) pdm09.",
author = "N. Turner and N. Pierse and Huang, {Q. S.} and S. Radke and A. Bissielo and Thompson, {M. G.} and H. Kelly and {on behalf of the SHIVERS investigation team} and Colin McArthur",
year = "2014",
month = "10",
day = "23",
language = "English",
volume = "19",
journal = "Eurosurveillance",
issn = "1025-496X",
publisher = "European Centre for Disease Prevention and Control",
number = "42",

}

Turner, N, Pierse, N, Huang, QS, Radke, S, Bissielo, A, Thompson, MG, Kelly, H & on behalf of the SHIVERS investigation team 2014, 'Interim estimates of the effectiveness of seasonal trivalent inactivated influenza vaccine in preventing influenza hospitalisations and primary care visits in Auckland, New Zealand, in 2014', Eurosurveillance, vol. 19, no. 42.

Interim estimates of the effectiveness of seasonal trivalent inactivated influenza vaccine in preventing influenza hospitalisations and primary care visits in Auckland, New Zealand, in 2014. / Turner, N.; Pierse, N.; Huang, Q. S.; Radke, S.; Bissielo, A.; Thompson, M. G.; Kelly, H.; on behalf of the SHIVERS investigation team.

In: Eurosurveillance, Vol. 19, No. 42, 23.10.2014.

Research output: Contribution to journalArticleResearchpeer-review

TY - JOUR

T1 - Interim estimates of the effectiveness of seasonal trivalent inactivated influenza vaccine in preventing influenza hospitalisations and primary care visits in Auckland, New Zealand, in 2014

AU - Turner, N.

AU - Pierse, N.

AU - Huang, Q. S.

AU - Radke, S.

AU - Bissielo, A.

AU - Thompson, M. G.

AU - Kelly, H.

AU - on behalf of the SHIVERS investigation team

AU - McArthur, Colin

PY - 2014/10/23

Y1 - 2014/10/23

N2 - We present preliminary results of influenza vaccine effectiveness (VE) in New Zealand using a case test- negative design for 28 April to 31 August 2014. VE adjusted for age and time of admission among all ages against severe acute respiratory illness hospital presentation due to laboratory-confirmed influenza was 54% (95% CI: 19 to 74) and specifically against A(H1N1) pdm09 was 65% (95% CI:33 to 81). For influenza-con- firmed primary care visits, VE was 67% (95% CI: 48 to 79) overall and 73% (95% CI: 50 to 85) against A(H1N1) pdm09.

AB - We present preliminary results of influenza vaccine effectiveness (VE) in New Zealand using a case test- negative design for 28 April to 31 August 2014. VE adjusted for age and time of admission among all ages against severe acute respiratory illness hospital presentation due to laboratory-confirmed influenza was 54% (95% CI: 19 to 74) and specifically against A(H1N1) pdm09 was 65% (95% CI:33 to 81). For influenza-con- firmed primary care visits, VE was 67% (95% CI: 48 to 79) overall and 73% (95% CI: 50 to 85) against A(H1N1) pdm09.

UR - http://www.scopus.com/inward/record.url?scp=84908528902&partnerID=8YFLogxK

M3 - Article

VL - 19

JO - Eurosurveillance

JF - Eurosurveillance

SN - 1025-496X

IS - 42

ER -